Liquidia Corporation to Present at the 2025 Wells Fargo Healthcare Conference

Rhea-AI Summary

Liquidia Corporation (NASDAQ: LQDA) announced its participation in the upcoming 2025 Wells Fargo Healthcare Conference. The company's executive leadership team will conduct a fireside chat on Wednesday, September 3, 2025, at 3:45 p.m. ET in Boston.

Investors and interested parties can access the presentation via webcast through Liquidia's website. A recorded version will remain available for at least 30 days after the event on the company's investor relations page.

MORRISVILLE, N.C., Aug. 27, 2025 (GLOBE NEWSWIRE) -- Liquidia Corporation (NASDAQ: LQDA) announced today that members of the company’s executive leadership team will be providing an update on the company's business during a fireside chat at the 2025 Wells Fargo Healthcare Conference on Wednesday, September 3, 2025, beginning at 3:45 p.m. ET in Boston.

Access to a webcast of the presentation will be available to investors and other interested parties by accessing Liquidia’s website at https://liquidia.com/investors/events-and-presentations. An archived, recorded version of the presentation will be available on Liquidia’s website for at least 30 days following the event.

About Liquidia Corporation
Liquidia Corporation is a biopharmaceutical company developing innovative therapies for patients with rare cardiopulmonary disease. The company’s current focus spans the development and commercialization of products in pulmonary hypertension and other applications of its proprietary PRINT^® Technology. PRINT enabled the creation of Liquidia’s first approved product, YUTREPIA™ (treprostinil) inhalation powder for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).  The company is also developing L606, an investigational sustained-release formulation of treprostinil administered twice-daily with a next-generation nebulizer, and currently markets generic Treprostinil Injection for the treatment of PAH. To learn more about Liquidia, please visit www.liquidia.com.

Contact Information

Investors:
Jason Adair
Chief Business Officer
919.328.4350
jason.adair@liquidia.com

Media:
Patrick Wallace
Director, Corporate Communications
919.328.4383
patrick.wallace@liquidia.com

FAQ

When is Liquidia Corporation (LQDA) presenting at the Wells Fargo Healthcare Conference 2025?

Liquidia Corporation will present on Wednesday, September 3, 2025, at 3:45 p.m. ET in Boston.

How can investors access Liquidia's (LQDA) Wells Fargo Healthcare Conference presentation?

Investors can access the presentation via webcast through Liquidia's website at liquidia.com/investors/events-and-presentations.

How long will Liquidia's (LQDA) Wells Fargo conference presentation recording be available?

The recorded presentation will be available on Liquidia's website for at least 30 days following the event.

What format will Liquidia's (LQDA) presentation take at the Wells Fargo Healthcare Conference?

The presentation will be in the format of a fireside chat featuring members of Liquidia's executive leadership team.